Compounds > acamprosate

Page last updated: 2024-08-25

acamprosate and buprenorphine

acamprosate has been researched along with buprenorphine in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (11.11)	18.2507
2000's	3 (33.33)	29.6817
2010's	4 (44.44)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Allen, JP; Litten, RZ	1
Cador, M; Koob, GF; Stinus, L; Zorrilla, EP	1
Kassed, CA; Kranzler, HR; Levit, KR; Mark, TL; Vandivort-Warren, R	1
Chand, PK; Thirthalli, J	1
Abraham, AJ; Knudsen, HK; Roman, PM	1
Friedmann, PD; Park, TW	1
Creedon, TB; Hodgkin, D; Horgan, CM; Matteucci, AM; Reif, S; Stewart, MT	1
Binswanger, IA; Fazel, S; Hellner, C; Larsson, H; Molero, Y; Zetterqvist, J	1
Hulme, J; Sheikh, H; Wiercigroch, D	1

Reviews

3 review(s) available for acamprosate and buprenorphine

Article	Year
Medications for alcohol, illicit drug, and tobacco dependence. An update of research findings. Journal of substance abuse treatment, 1999, Volume: 16, Issue:2 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Bupropion; Forecasting; Humans; Methadyl Acetate; Naltrexone; Substance-Related Disorders; Taurine; Tobacco Use Disorder	1999
The implications of medication development in the treatment of substance use disorders in developing countries. Current opinion in psychiatry, 2009, Volume: 22, Issue:3 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Comorbidity; Developing Countries; Disulfiram; HIV Infections; Humans; Methadone; Narcotic Antagonists; Prevalence; Public Policy; Substance Abuse, Intravenous; Substance-Related Disorders; Taurine	2009
Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders. Rhode Island medical journal (2013), 2014, Oct-01, Volume: 97, Issue:10 Topics: Acamprosate; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Directive Counseling; Disulfiram; Humans; Methadone; Naltrexone; Narcotic Antagonists; Practice Patterns, Physicians'; Substance-Related Disorders; Taurine; United States	2014

Other Studies

6 other study(ies) available for acamprosate and buprenorphine

Article	Year
Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:1 Topics: Acamprosate; Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Avoidance Learning; Buprenorphine; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Implants; Fluoxetine; Lisuride; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Substance Withdrawal Syndrome; Taurine	2005
Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. Drug and alcohol dependence, 2009, Jan-01, Volume: 99, Issue:1-3 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Delayed-Action Preparations; Disulfiram; Drug Costs; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Humans; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Osteopathic Medicine; Physicians; Physicians, Family; Psychiatry; Taurine; United States	2009
Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation. Addictive behaviors, 2011, Volume: 36, Issue:6 Topics: Acamprosate; Alcohol Deterrents; Buprenorphine; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Patient Education as Topic; Substance Abuse Treatment Centers; Substance-Related Disorders; Taurine; United States	2011
Access to Addiction Pharmacotherapy in Private Health Plans. Journal of substance abuse treatment, 2016, Volume: 66 Topics: Acamprosate; Buprenorphine; Cost Sharing; Evidence-Based Practice; Formularies as Topic; Health Services Accessibility; Humans; Insurance, Health; Naltrexone; Substance-Related Disorders; Surveys and Questionnaires; Taurine; United States	2016
Medications for Alcohol and Opioid Use Disorders and Risk of Suicidal Behavior, Accidental Overdoses, and Crime. The American journal of psychiatry, 2018, 10-01, Volume: 175, Issue:10 Topics: Acamprosate; Adult; Aged; Alcohol Deterrents; Alcoholism; Buprenorphine; Cohort Studies; Crime; Drug Overdose; Female; Follow-Up Studies; Humans; Male; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Risk Factors; Suicidal Ideation; Young Adult	2018
A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use. Substance abuse treatment, prevention, and policy, 2020, 01-13, Volume: 15, Issue:1 Topics: Acamprosate; Addiction Medicine; Adult; Aged; Alcohol Deterrents; Alcoholism; Buprenorphine; Emergency Service, Hospital; Female; Gabapentin; Humans; Male; Middle Aged; Naltrexone; Ontario; Opioid-Related Disorders; Patient Acceptance of Health Care; Primary Health Care; Referral and Consultation; Socioeconomic Factors; Substance Abuse Treatment Centers; Substance-Related Disorders; Time Factors; Young Adult	2020